MDPI and ACS Style
Kovaleva, A.; Poluektova, E.; Maslennikov, R.; Karchevskaya, A.; Shifrin, O.; Kiryukhin, A.; Tertychnyy, A.; Kovalev, L.; Kovaleva, M.; Lobanova, O.;
et al. Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial. J. Clin. Med. 2023, 12, 6064.
https://doi.org/10.3390/jcm12186064
AMA Style
Kovaleva A, Poluektova E, Maslennikov R, Karchevskaya A, Shifrin O, Kiryukhin A, Tertychnyy A, Kovalev L, Kovaleva M, Lobanova O,
et al. Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial. Journal of Clinical Medicine. 2023; 12(18):6064.
https://doi.org/10.3390/jcm12186064
Chicago/Turabian Style
Kovaleva, Aleksandra, Elena Poluektova, Roman Maslennikov, Anna Karchevskaya, Oleg Shifrin, Andrey Kiryukhin, Aleksandr Tertychnyy, Leonid Kovalev, Marina Kovaleva, Olga Lobanova,
and et al. 2023. "Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial" Journal of Clinical Medicine 12, no. 18: 6064.
https://doi.org/10.3390/jcm12186064
